3Sherief AM, Elsafy UR, Abdelkhalek, et al. Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt [J]. Mol Clin Oncol, 2015, 3(1) : 139 -144. 被引量：1
4Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research [ J ]. Hematology Am Soc Hematol Educ Program, 2009:523 -531. 被引量：1
2Kobayashi H, Iehikawa M, Hangaishi A, et al. Concurrent develop- ment of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin. Int J Haema- tol,2011 ;93(1) :112 -117. 被引量：1
3Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lympho- ma. Blood,2004 ; 104 (10) :3009 - 3020. 被引量：1
4Kian TC, Miriam T, Richard Q,et al. Clinical characteristics, prognos- tic factors and outcomes of Burkitt lymphoma in adult Asians. Leuk Lymphoma,2008 ;49 ( 4 ) : 824 - 827. 被引量：1
5Perkins AS, Friedberg JW. Burkitt Lymphoma in Adults. Hematolo- gy Am Soc Hematol Edue Program,2008 ;16:341 -348. 被引量：1
6Cairo MS, Coiffier B, Reiter A, et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haemato1,2010 ; 149 (4) : 578 - 586. 被引量：1
7Rizzieri DA, Johnson JL, Niedzwiecki D, et aL Intensive chemo- therapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of cancer and leukemia group B study 9251. Cancer,2004 ; 100 ( 7 ) : 1438 - 1448. 被引量：1
8Lacasce A, Howard O, Lib S, et al. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphoma: preserved efficacy with decreased toxicity. Leuk Lymphoma, 2004 ;45 (4) :761 - 767. 被引量：1
9Maruyama D, Watanabe T, Maeshima AM, et al. Modified cyclo- phosphamide, vincristine, doxorubicin, and methotrexate ( CODOX- M)/ifosfamide, etoposide,and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermedi- ate between diffuse large B cell lymphoma and BL. Int J Haematol, 2010;92(5) :732 -743. 被引量：1
10Du J, Wang H, Zhong C, et al. Crystal structure of chimeric antibody C2H7 Fah in complex with a CD20 peptide. Mol Immunol,2008 ;45 (10) :2861 -2868. 被引量：1
